How important is the home market for cross - listed biotech companies?

Theodore Panagiotidis () and Pavlos Tsiokas ()
Additional contact information
Theodore Panagiotidis: Department of Economics, University of Macedonia, Greece

Working Paper series from Rimini Centre for Economic Analysis

Abstract: This study investigates five German biotechnology firms cross-listed on XETRA and NASDAQ. By employing high-frequency data, we estimate both bivariate and trivariate vector error correction models—the latter explicitly accounting for exchange rate dynamics—to assess which market, domestic or U.S., leads in price discovery. The results suggest that XETRA plays a dominant role for larger firms, whereas smaller firms are more influenced by NASDAQ. Simulations show that bivariate models—common in the literature— yield biased results under volatile exchange rate conditions, whereas trivariate models produce more robust estimates. Finally, exchange rate shocks affect NASDAQ and XETRA differently.

Keywords: Cointegration; Impulse response functions (search for similar items in EconPapers)
JEL-codes: G1 (search for similar items in EconPapers)
Date: 2025-07
New Economics Papers: this item is included in nep-cba, nep-mac and nep-mon
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://rcea.org/RePEc/pdf/wp25-07.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:rim:rimwps:25-07

Access Statistics for this paper

More papers in Working Paper series from Rimini Centre for Economic Analysis Contact information at EDIRC.
Bibliographic data for series maintained by Marco Savioli ().